BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7835119)

  • 1. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY; Cole LA; Kardana A
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies.
    Nishimura R; Utsunomiya T; Ide K; Kitajima T; Chen HC; Strobel JL; Hussa RO; Mochizuki M
    Jpn J Cancer Res; 1987 Aug; 78(8):833-9. PubMed ID: 3115930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular weight and fragmentation of human chorionic gonadotropin in urine in patients with trophoblastic diseases].
    Ide K; Nishimura R; Kitajima T; Utsunomiya T; Tanabe K; Yuki Y; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):160-6. PubMed ID: 2834473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals.
    Mizuochi T; Nishimura R; Taniguchi T; Utsunomiya T; Mochizuki M; Derappe C; Kobata A
    Jpn J Cancer Res; 1985 Aug; 76(8):752-9. PubMed ID: 3930453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluctuations in the level of chorionic gonadotropin in the process of primary treatment of trophoblastic tumors].
    SemenovskiÄ­ AV
    Akush Ginekol (Mosk); 1978 Dec; (12):21-4. PubMed ID: 216278
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural differences found in the asparagine-linked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and with choriocarcinoma.
    Endo T; Nishimura R; Kawano T; Mochizuki M; Kobata A
    Cancer Res; 1987 Oct; 47(19):5242-5. PubMed ID: 2957051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N; Okamoto M; Tomoda Y
    Obstet Gynecol; 1973 Jul; 42(1):1-11. PubMed ID: 4352641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.